BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1091 related articles for article (PubMed ID: 15317270)

  • 1. A randomized, controlled study of specific immunotherapy in monosensitized subjects with seasonal rhinitis: effect on bronchial hyperresponsiveness, sputum inflammatory markers and development of asthma symptoms.
    Crimi N; Li Gotti F; Mangano G; Paolino G; Mastruzzo C; Vancheri C; Lisitano N; Polosa R
    Ann Ital Med Int; 2004; 19(2):98-108. PubMed ID: 15317270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of immunotherapy on asthma progression, BHR and sputum eosinophils in allergic rhinitis.
    Polosa R; Li Gotti F; Mangano G; Paolino G; Mastruzzo C; Vancheri C; Lisitano N; Crimi N
    Allergy; 2004 Nov; 59(11):1224-8. PubMed ID: 15461606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monitoring of seasonal variability in bronchial hyper-responsiveness and sputum cell counts in non-asthmatic subjects with rhinitis and effect of specific immunotherapy.
    Polosa R; Li Gotti F; Mangano G; Mastruzzo C; Pistorio MP; Crimi N
    Clin Exp Allergy; 2003 Jul; 33(7):873-81. PubMed ID: 12859441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Grass pollen immunotherapy for seasonal rhinitis and asthma: a randomized, controlled trial.
    Walker SM; Pajno GB; Lima MT; Wilson DR; Durham SR
    J Allergy Clin Immunol; 2001 Jan; 107(1):87-93. PubMed ID: 11149996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Grass pollen immunotherapy as an effective therapy for childhood seasonal allergic asthma.
    Roberts G; Hurley C; Turcanu V; Lack G
    J Allergy Clin Immunol; 2006 Feb; 117(2):263-8. PubMed ID: 16461125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of nasal triamcinolone acetonide on seasonal variations of bronchial hyperresponsiveness and bronchial inflammation in nonasthmatic children with seasonal allergic rhinitis.
    Orhan F; Sekerel BE; Adalioglu G; Pinar M; Tuncer A
    Ann Allergy Asthma Immunol; 2004 Apr; 92(4):438-45. PubMed ID: 15104196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The type of sensitizing allergen can affect the evolution of respiratory allergy.
    Marogna M; Massolo A; Berra D; Zanon P; Chiodini E; Canonica GW; Passalacqua G
    Allergy; 2006 Oct; 61(10):1209-15. PubMed ID: 16942571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A double-blinded, comparative study of the effects of short preseason specific immunotherapy and topical steroids in patients with allergic rhinoconjunctivitis and asthma.
    Rak S; Heinrich C; Jacobsen L; Scheynius A; Venge P
    J Allergy Clin Immunol; 2001 Dec; 108(6):921-8. PubMed ID: 11742269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sublingual immunotherapy abrogates seasonal bronchial hyperresponsiveness in children with Parietaria-induced respiratory allergy: a randomized controlled trial.
    Pajno GB; Passalacqua G; Vita D; Caminiti L; Parmiani S; Barberio G
    Allergy; 2004 Aug; 59(8):883-7. PubMed ID: 15230823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination of omalizumab and specific immunotherapy is superior to immunotherapy in patients with seasonal allergic rhinoconjunctivitis and co-morbid seasonal allergic asthma.
    Kopp MV; Hamelmann E; Zielen S; Kamin W; Bergmann KC; Sieder C; Stenglein S; Seyfried S; Wahn U;
    Clin Exp Allergy; 2009 Feb; 39(2):271-9. PubMed ID: 19016798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of grass pollen allergoid immunotherapy on clinical and immunological parameters in children with allergic rhinitis.
    Keskin O; Tuncer A; Adalioglu G; Sekerel BE; Saçkesen C; Kalayci O
    Pediatr Allergy Immunol; 2006 Sep; 17(6):396-407. PubMed ID: 16925684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rush sublingual immunotherapy in Parietaria allergic patients.
    D'Ambrosio FP; Ricciardi L; Isola S; Savi E; Parmiani S; Puccinelli P; Musarra A
    Allergol Immunopathol (Madr); 1996; 24(4):146-51. PubMed ID: 8939269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of 1-year specific immunotherapy with standardized house dust mite vaccine on mild to moderate allergic asthmatic patients].
    Wang HY; Lin XP; Hao CL; Zhang CQ; Sun BQ; Zheng JP; Chen P; Sheng JY; Wu A; Zhong NS
    Zhonghua Jie He He Hu Xi Za Zhi; 2006 Oct; 29(10):679-87. PubMed ID: 17129496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the antiinflammatory and clinical effects of sublingual immunotherapy with carbamylated allergoid in allergic asthma with or without rhinitis. A 12-month perspective randomized, controlled, trial.
    La Grutta S; Arena A; D'Anneo WR; Gammeri E; Leonardi S; Trimarchi A; Platania D; La Rosa M
    Eur Ann Allergy Clin Immunol; 2007 Feb; 39(2):40-4. PubMed ID: 17441414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in airway inflammation following nasal allergic challenge in patients with seasonal rhinitis.
    Bonay M; Neukirch C; Grandsaigne M; Leçon-Malas V; Ravaud P; Dehoux M; Aubier M
    Allergy; 2006 Jan; 61(1):111-8. PubMed ID: 16364165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Preventive immunotherapy].
    Boquete M; Carballada F; Expósito F; González A
    Allergol Immunopathol (Madr); 2000; 28(3):89-93. PubMed ID: 10867376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Bronchial reactivity in patients with seasonal allergic rhinitis].
    Gudelj I; Plavec D; Susac A; Cvitanović S; Tudorić N
    Lijec Vjesn; 2002 Oct; 124(10):305-9. PubMed ID: 12619439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Double-blind, placebo-controlled study with a modified therapeutic vaccine of Salsola kali (Russian thistle) administered through use of a cluster schedule.
    Colás C; Monzón S; Venturini M; Lezaun A
    J Allergy Clin Immunol; 2006 Apr; 117(4):810-6. PubMed ID: 16630938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of specific immunotherapy with SQ allergen extract in treatment-resistant seasonal allergic rhinoconjunctivitis.
    Frew AJ; Powell RJ; Corrigan CJ; Durham SR;
    J Allergy Clin Immunol; 2006 Feb; 117(2):319-25. PubMed ID: 16461133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of subcutaneous immunotherapy with a biologically standardized extract of Ambrosia artemisiifolia pollen: a double-blind, placebo-controlled study.
    Mirone C; Albert F; Tosi A; Mocchetti F; Mosca S; Giorgino M; Pecora S; Parmiani S; Ortolani C
    Clin Exp Allergy; 2004 Sep; 34(9):1408-14. PubMed ID: 15347374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 55.